tirzepatide attenuates mammary tumor progression in diet induced obese mice a promising new study, the widely used weight-loss drug tirzepatide—known commercially as Mounjaro for diabetes and Zepbound for obesity—has shown a surprising secondary benefit: shrinking breast cancer tumors in Pack:1 Pack Interest in Treatment with Glucose Support

tirzepatide attenuates mammary tumor progression in diet induced obese mice a promising new study, the widely used weight-loss drug tirzepatide—known commercially as Mounjaro for diabetes and Zepbound for obesity—has shown a surprising secondary benefit: shrinking breast cancer tumors in Pack:1 Pack Interest in Treatment with Glucose Support

Interest in Treatment with GLP-1 Receptor Agonists for the Management of Insufficient Weight Loss or Weight Regain After Bariatric Surgery | Obesity Surgery | Springer Nature Link

This is a classic injection site reaction, and it happens to 3-7% of tirzepatide users

Glucose Support

Pack:1 Pack

Drugs adopting this strategy produced body weight reduction more than 20%